Percentage and localization of engrafted human SPIOs-labeled CD133(+) BMDSCs by Prussian blue staining. Human CD133(+) BMDSCs were obtained from patients undergoing autologous cell therapy in refractory AS and endometrial atrophy, labeled with SPIOs and injected either intrauterinely (n = 5) or systemically through the tail vein (n = 5) in the animal model.Īccumulation of collagen and glycosaminoglycan deposits detected by trichrome staining.
#Ivi valencia code
Nonobese diabetic mice (strain code 394 NOD.CB17- Prkdc(scid)/NcrCrl) in which AS was induced according to a published protocol. To investigate the engraftment and proliferation of superparamagnetic iron oxide nanoparticles (SPIOs)-labeled human CD133(+) bone marrow-derived stem cells (BMDSCs) in an animal model of Asherman syndrome (AS). 7 Fundación Instituto Valenciano de Infertilidad (FIVI), Department of Obstetrics & Gynecology, School of Medicine, Valencia University and Instituto Universitario IVI/INCLIVA, Valencia, Spain School of Medicine, Valencia University, Valencia, Spain Department of Obstetrics & Gynecology, Stanford University School of Medicine, Stanford University, Stanford, California.6 Fundación Instituto Valenciano de Infertilidad (FIVI), Department of Obstetrics & Gynecology, School of Medicine, Valencia University and Instituto Universitario IVI/INCLIVA, Valencia, Spain Instituto Valenciano Infertilidad (IVI) Valencia, Valencia, Spain.5 School of Medicine, Valencia University, Valencia, Spain.
4 Instituto Valenciano Infertilidad (IVI) Valencia, Valencia, Spain.3 Instituto Valenciano Infertilidad (IVI) Barcelona, Barcelona, Spain.Electronic address: 2 Fundación Instituto Valenciano de Infertilidad (FIVI), Department of Obstetrics & Gynecology, School of Medicine, Valencia University and Instituto Universitario IVI/INCLIVA, Valencia, Spain. 1 Fundación Instituto Valenciano de Infertilidad (FIVI), Department of Obstetrics & Gynecology, School of Medicine, Valencia University and Instituto Universitario IVI/INCLIVA, Valencia, Spain.
0 kommentar(er)
